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Wound infections and seroma formations are important problems in ventral hernia
repair operations using synthetic mesh grafts. The aim of this study was to investigate
the effect of the use of synthetic mesh soaked in vancomycin solution on the rate of
graft infection. The total number of subjects was 52. The subjects were randomized into
2 groups using a software program. Group 1 (n¼26) was the control group. In group 2 (n
¼ 26), synthetic mesh was soaked in a Vancomycin solution before it was implanted.
The patients were compared with respect to demographic characteristics and
preoperative, intraoperative, and postoperative variables. There were no significant
differences between the groups with respect to the available variables. Seroma
development was significantly more common in group 2 (P , 0.041). Three patients
(5.7%) developed superficial wound infection, and 9 (17%) developed surgical site
infection 2–type wound-site infection. No significant difference was found between the
groups in terms of infection. The use of synthetic mesh soaked in vancomycin solution
had no beneficial effects on the rate of wound-site infection. Future randomized,
controlled, large-scale studies using the same mesh and suture types, and meshes
soaked in larger spectrum antibiotics are needed.
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Ventral hernia repair (VHR) is a commonsurgical procedure in general surgical practice.
More than 365,000 VHR are performed in the United
States alone each year.1 Use of synthetic mesh
significantly reduces recurrence rates, and it is the
recommended standard for VHR.2 VHR operation
using mesh is associated with reduced early and late
recurrences compared with repairs using primary
suture.3–5 However, the use of mesh may cause
small bowel stenosis, surgical field infection, mesh-
to-skin sinus formation, and enterocutaneous fistu-
la.6,7 As with all other synthetic materials, mesh use
in VHR also carries a risk of infection.8 VHR with
mesh use is associated with an infection rate of up to
16%.2,8–10 This significant complication causes in-
creased patient morbidity. Moreover, it leads to
removal of synthetic material, prolonged antibiotic
therapy, longer hospital stay, additional surgical
interventions, and significantly higher costs.9 Meth-
icillin-resistant Staphylococcus aureus (MRSA) is the
most common microorganism isolated from the
mesh infections.11,12 Reducing the rate of infection
with strains of staphylococcus, the members of skin
flora, which are the most common pathogens in
mesh infections, may be accomplished by using
meshes soaked in Vancomycin solution.13 Ventral
incisional hernia, one of the most important com-
plications of abdominal surgical operations, and the
umbilical hernia, commonly observed in obese
patients, still cause trouble for surgeons despite
technical advances. In particular, synthetic mesh
infections after hernia repair lead to significant
clinical (patient morbidity and mortality) and social
(cost, loss of labor force, etc.) problems. An animal
study aiming to reduce these high-morbidity com-
plications found that the use of synthetic mesh
materials soaked in Vancomycin (Vancomycin, Ab-
bott, Chicago, Illinois) may reduce the infection
rate.13 One inexpensive method commonly em-
ployed by surgeons to potentially reduce mesh
infections is to soak the mesh in antibiotic solutions
prior to implantation. Despite this common clinical
practice, there was no available study to investigate
the effect of use of synthetic mesh soaked in
antibiotic solution on graft infection. So far, only 2
studies have investigated the effect of mesh soaked
in antibiotic solution on infection rates, and both of
them were animal studies.13,14 Furthermore, no
prospective clinical study has as yet explored the
effect of the use of propylene mesh soaked in
antibiotic solution on the infection rate.
The aim of the present study was to investigate
the impact of the use of synthetic mesh soaked in
Vancomycin solution on the risk of graft infection in
a homogenous patient population in which only
polypropylene mesh was used.
Material and Methods
Study design
This study included patients who underwent
synthetic mesh implantation via open technique
for VHR at Adana Baskent University Application
and Research Hospital, Department of General
Surgery, between November 2013 and October
2014. This study was approved by Baskent Univer-
sity Institutional Review Board. The total number of
study participants was 71. Patients who declined
operation, underwent laparoscopic VHR, had repair
with a technique other than synthetic mesh use, had
a simultaneous operation, or had an urgent opera-
tion were excluded (17 patients). Synthetic mesh
was removed in 2 patients who developed small
intestinal perforation or stenosis, and they were
excluded from the trial. As a result, 19 patients were
excluded from the study. The patients were allocat-
ed into 2 groups by the order of randomization
according to software (available at http://stattrek.
com/site/about.aspx). In group 1 (n ¼ 26), the
synthetic mesh was soaked in 0.9% saline solution
15 minutes before implantation. In group 2 (n¼ 26),
the synthetic mesh was soaked in Vancomycin
solution (10 mg/mL) 15 minutes before implanta-
tion. All patients were evaluated in terms of age,
sex, type and number of previous surgical interven-
tions, body mass index (BMI), comorbidities, syn-
thetic material used, previous incision site, surgical
technique used for hernia repair, operation time,
hernia size, mesh size, suture material used for
abdominal closure, amount and dose of antibiotic
used for prophylaxis, drain use, time of drain
removal, the postoperative day of infection devel-
opment, types of medical and surgical treatments
applied after diagnosing the infection, type of
pathogen proliferating in tissue culture, other
postoperative complications, wound-site revision,
number of revisions, follow-up duration, Valve
Anti-Cheat (VAC) system use, early-term recur-
rence, mesh removal, and mortality. All patients
were managed in a single center by the same
University Hospital team.
Perioperative period
The patients were admitted the day before the
operation. All patients completed a surgical in-
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formed-consent form. Skin cleansing was performed
the night before the operation if necessary. All
patients received antibiotic prophylaxis prior to the
operation, before entering the operating room (2 g
first-generation cephalosporin (Sefazol, Mustafa
Nevzat, Istanbul, Turkey).
Meshes, sutures, and operative procedures
Heavyweight macroporous polypropylene meshes
were used for all patients. All meshes used in
hernias were fixed by nonabsorbable monofilament
polypropylene sutures (Prolene Mesh, Ethicon,
Sommerville, New Jersey). Hernia repair with graft
was performed under general anesthesia. The hernia
and mesh size were determined by the operating
surgeon at the operating table. All operations (100%)
were considered clean according to the criteria of
the National Academy of Sciences/National Re-
search Council.15 The wounds were routinely
reevaluated at the second postoperative day during
the first dressing change. The skin sutures were
removed at 10th or 14th day after the operation.
Postoperative care
All patients received systemic antibiotic therapy
during the first 2 postoperative days, and low
molecular heparin was routinely administered.
Early mobilization was the rule, usually on the
evening of surgery. Patients’ abdominal incisions
were routinely examined every week after surgery.
An abdominal binder was required for 12 weeks
after surgery until the date of the first follow-up
consultation.
Treatment and documentation of mesh graft infection
All patients were evaluated by the same surgeon
after the operation. The diagnosis of superficial
surgical field infection was made on the basis of the
existence of cardinal signs and symptoms of
infection including redness, edema, locally in-
creased temperature, and purulent discharge. A
more advanced classification of infections was made
according to the current Centers for Disease Control
and Prevention (CDC) criteria16 and included
surgical site infection 1 (SSI 1; superficial), SSI 2
(deep surgical field), and SSI 3 (organ/space
surgical field) types. In the case of infection, the
sutures were removed, and a smear culture from the
wound was sent for culture proliferation that
dictated the antibiotic therapy. The wound size
was measured at the start of infection and during
treatment. All patients were managed with periodic
dressing changes, wound irrigation, and fluid
absorbers on the basis of the European Wound
Management Association (EWMA) guideline.17 A
large-sized open wound accompanied by graft
infection or a clearly infected graft was treated with
the use of VAC. As a general rule, secondary wound
closure was avoided because an open wound may
have caused activation of infection. Wounds with a
large opening, no proliferation in control smear
cultures, and adequate granulation tissue were
primarily sutured. Antibiotic therapy was regularly
continued and adjusted according to the culture
results.
Statistical analysis
Statistical analysis was performed using the statis-
tical package SPSS software (Version 17.0, SPSS Inc,
Chicago, Illinois). If continuous variables were
normal, they were described as the mean 6 SD [P
. 0.05 in Kolmogorov-Smirnov test or Shapiro-Wilk
(n , 30)], and if the continuous variables were not
normal, they were described as the median. Com-
parisons between sex and BMI were applied using
Student t test for normally distributed data. The
categoric variables between the groups were ana-
lyzed using the v2 test or Fisher exact test. Values of
P , 0.05 were considered statistically significant.
Results
A total of 52 patients underwent open VHR with a
synthetic mesh. The demographic variables were
not significantly different between groups. Six
patients had more than 1 comorbidity, and 3 patients
had diabetes mellitus. The study data are summa-
rized in Table 1. The complication rates were higher
in group 2. As for the type of complication, seroma
development was significantly more common in
group 2 (P , 0.041). Yet, the overall complication
rates were not significantly different between
groups. The distributions of the complications are
shown in Table 2. There were no significant
differences between groups with respect to intraop-
erative and postoperative variables. These results
are presented in Table 3. A total of 12 (23%) patients
developed wound infection. Of these, 3 (5.7%) had
superficial infection, while 9 (17%) had SSI 2–type
wound-site infection. A sample was sent for culture
from the wound-site aspiration fluid in 9 patients
who developed SSI 2–type wound-site infection; 8 of
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them had culture proliferation. One patient did not
have culture proliferation. Of the 9 patients, 7 were
in group 2, and 2 in group 1. No significant
difference was found between groups. The 9
patients were compared between the groups and
in overall patient population with respect to mean
operation time, mesh size, hernia size, and BMI, and
no significant difference was observed. The patho-
gens that proliferated in culture are summarized in
Table 4. The incision type of the previous operation
was compared between the groups and in the
overall patient population, and no significant
difference was detected. The most common incision
types in both groups were midline, xiphoid to pubis.
The incision types are shown in Table 5. Among 9
patients who developed SSI 2–type infection, 5 had
seroma and 1 had bleeding prior to infection. All 5
patients having seroma were in group 2. Of 9
patients developing SSI 2, 7 underwent wound-site
revision. Three patients received VAC. The synthetic
mesh was totally removed in 2 patients and partially
in 1 patient. All 3 patients with mesh removal were
in group 2. Mesh was preserved via conservative
follow-up in 6 patients. Three patients developed
SSI 1–wound-site infection, and they received
wound care and oral antibiotics. A total of 9 patients
underwent wound-site revision. Six (66%) of them
had more than 1 revision operation; the mean
number of revisions was 2.1 (range, 1–4). Of them,
7 were the patients having SSI 2–type proliferation.
None of the patients died.
Discussion
SSI 2 developing after VHR with synthetic mesh
continues to be a significant problem for both
patients and surgeons. The rate of synthetic mesh
infection after VHR ranges from 5% to 16%.2,10,18,19
However, reporting a standard rate for all compli-
cations after VHR mostly yields different results.
This is because the patient groups are composed of
heterogeneous groups in the published series. For
patients in this group, the risk factors for surgical
field infections (i.e., infection, seroma, wound
dehiscence, or the formation of an enterocutaneous
fistula) were not properly differentiated from each
other.18,20,21
Synthetic mesh infection arising after VHR causes
serious complications, including increased patient
morbidity, re-operation rates, hospital cost, and
hernia recurrence.8,22 It also leads to wound revi-
sion, mesh removal, and abdominal re-operations.23
Determining methods that are cost-effective, readily
available, and easy to use in routine practice to
reduce synthetic mesh infections may provide better
results for patients undergoing VHR. The majority
of synthetic mesh infections are caused by patho-
gens found in normal skin flora. Staphylococcus
aureus and Staphylococcus epidermidis are the most
common bacteria in skin flora.24 S aureus is
responsible for more than 75% of all mesh infec-
tions.9 However, a member of Staphylococci family
was the causative agent in 3 of 8 patients (37%) with
culture proliferation (Table 4). Bacteria of normal
Table 1 Demographics and clinical data of the patients
Parameters Group 1 Group 2 Total
Number of patients, n 26 26 52
Sex, male/female 8/18 11/15 19/33
Age, n (median) 53 (31–74) 54 (31–78) 53 (31–78)
BMI, kg/m2
,30 9 (34.6) 9 (34.6) 18 (34.6)
.30 17 (65.4) 17 (65.4) 34 (65.4)
Comorbidities, n (%) 8 (30.8) 17 (65.4) 25 (48.1)
Smoking, n (%) 4 (15.3) 5 (9.6) 13 (25)
Steroids/immunosuppression, n (%) – – –
Table 2 Complications after VHR
Complications Group 1 Group 2 Total P
Seroma formation, n (%) 1 (3.8) 7 (26.9) 8 (15.4) 0.041
Bleeding, n (%) – 1 (3.8) 1 (1.9) 0.05
Wound infections
SSI 2, n (%) 2 (7.7) 7 (26.9) 9 (17.3) 0.05
SSI 1, n (%) 2 (7.7) 1 (3.8) 3 (5.8) 0.05
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skin flora are frequently isolated from postoperative
wound-site and synthetic-mesh infections. Thus,
skin sterilization, reducing mesh–skin contact, and
preoperative antibiotic use are important measures
to lower the bacterial load of the wound site. Hence,
in our study, all patients received prophylactic
antibiotic therapy, a proper surgical field cleansing
was carried out, and the wound edges were covered
by a sterile drape as soon as the mesh was brought
into the surgical field. When bacteria breach into
surgical incision, the development of mesh infection
depends on the bacterial adhesion to the synthetic
material. Mesh infection usually contains skin flora,
and therefore it probably occurs during mesh
placement. The adhesion rate varies by the synthetic
mesh used.13 In our study, all patients received a
synthetic polypropylene mesh. This ensured a
homogenous group in terms of bacterial adhesion.
Likewise, all patients were preoperatively prepared
and operated on by the same surgical team.
Preoperative care, positioning, and sterilization of
the patients were performed by the same ancillary
health care team.
Some mesh structures may alter the adherence
and biofilm properties of bacteria found in normal
skin flora after their contact with synthetic mesh.9,25
Compared with hydrophilic multifilament polyester
mesh, hydrophobic monofilament mesh (polypro-
pylene mesh) has been shown to reduce MRSA
growth.11,22,26 We used a polypropylene mesh in all
patients.
Augmentation of the antibiotic level within the
surgical wound to reduce mesh infections may be
accomplished by various methods. This idea has
been based on prophylactic intravenous antibiotic
use. However, this application has come into
question owing to the systemic side effects of drugs
and the lack of a consistent benefit.27 At this point,
novel treatment algorithms and applications have
come forth in an attempt to reduce surgical-field
infections. Efforts have been made to avoid the
systemic side effects of antibiotics and to provide
the surgical field with increased antibiotic concen-
trations.28 Some mesh manufacturers, therefore,
loaded antibacterial agents onto synthetic meshes.13
All the research and advances aim at reducing the
rate of mesh infections that occur after VHR and
lead to serious social and medical issues. Despite all
advances, however, mesh infections continue to be a
serious complication, with a rate of 16%.2,10 Ex-
tremely diverse risk factors may play a role in mesh
infections. A study defined coronary artery disease,
chronic obstructive pulmonary disease, low preop-
erative serum albumin, chronic steroid use, and
prolonged operative time as the risk factors for
surgical-field infections.21 Of 9 patients who devel-
oped SSI 2–type infection in our study, 2 had more
than one comorbidity, 1 had chronic obstructive
pulmonary disease, 1 had coronary artery disease,
and 1 had hypertension. The albumin level was
normal in all patients. None of our patients were
Table 4 Bacterial spectrum
Bacterial species Group 1 (n) Group 2 (n) Total (n)
Pseudomonas aeruginosa – 2 2
Coagulase-negative
Staphylococcus – 1 1
Staphylococcus aureus 1 – 1
Enterococcus faecalis – 1 1
Proteus mirabilis – 1 1
Escherichia coli – 1 1
S aureus þ E coli 1 – 1
Table 3 Intraoperative and postoperative variables
Parameters Group 1 Group 2 Total
Surgical technique, n (%)
Onlay repair (on the fascia) 1 (3.8) 4 (15.3) 5 (9.6)
Sublay repair (behind the muscle) 25 (96.1) 22 (84.6) 47 (90)
Operation time, min (median) 105 (60–240) 110 (60–180) 110 (60–240)
Use of drains, n (%) 24 (92.3) 26 (100) 50 (96)
Size of hernia defect, n (range) 88 (20–300) 81 (12–250) 85 (12–300)
Size of mesh graft used, n (range) 313 (112–450) 303 (50–450) 307 (50–450)
Use of nonabsorbable sutures, n (%) 26 (100) 26 (100) 52 (100)
Type of the mesh graft, n (%)
Polypropylene mesh 26 (100) 26 (100) 52 (100)
Wound revision, n (%) 3 (11.5) 6 (23) 9 (17.3)
Use of VAC, n (%) – 3 (11.5) 3 (5.7)
Removal of the prosthetic mesh, n (%) – 3 (11.5) 3 (5.7)
Use of postoperative antibiotics, n (%) 25 (96.1) 24 (92.3) 49 (94.2)
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using steroids or immunosuppressant drugs. How-
ever, operative variables were not considered
among the risk factors. Considering preoperative
risk factors alone is not sufficient when evaluating
surgical-field infections. We evaluated preoperative,
operative, and postoperative variables. The effect of
the variables on the infection rate was analyzed
statistically. A retrospective study encompassing 13
centers demonstrated that the rate of wound-site
infection was related to repair technique, preoper-
ative wound infection, smoking, chronic steroid use,
congestive heart failure, chronic obstructive pulmo-
nary disease, enterotomy, bowel resection, emergen-
cy procedure, prolonged operative time, inpatient
procedure, and total hospital stay.7,18,19 Since our
study did not include emergency cases and cases
with other concomitant surgeries, the variables such
as preoperative wound infection, enterotomy, bowel
resection, or emergency procedure had no impact on
the surgical-field infection of our patients.
The use of polyfilament mesh, the mesh size, and
the onlay mesh position are additional factors
affecting mesh infection.29 The effect of drain use
on infection risk is still controversial.29 In our study,
no polyfilament mesh was used in any of the
patients, a drain was used in only 2 patients in
group 1, and an onlay mesh was placed in only 5
patients. No significant differences were observed in
the intragroup and intergroup comparisons of these
parameters. Similarly, hernia size leading to the
width of dissection and, consequently, the mesh size
were not significantly different between groups.
Synthetic meshes used for VHR may be placed in
3 separate anatomic fields: the onlay, sublay
(preperitoneal), and intraperitoneal fields. Higher
complication rates have been reported in hernia
repairs done with synthetic mesh placed in onlay
and intraperitoneal fields.30 We, therefore, prefer
sublay repair in our routine clinical applications. An
onlay (prefascial) repair was performed in 5 of 52
patients (9.6%), and a sublay repair (retromuscular)
in 47 patients (90%). Eight of 9 patients (88%) who
developed SSI 2–type mesh infection underwent
sublay repair and 1 patient (12%) underwent onlay
repair. An increased dissection rate during sublay
repair may have contributed to a greater seroma
occurrence.
We did not find any statistically significant
differences between patient groups and in overall
patient group with respect to risk factors for SSI 2–
type mesh infection, including smoking, steroid/
immunosuppressant medication use, BMI, comor-
bidity (e.g., diabetes mellitus), hernia size, mesh
type, and prophylactic antibiotic use. However, 1
patient in group 1 and 7 patients in group 2 had
seroma, a factor that is considered to be a precursor
for mesh infection. Seroma developed in 5 out of 7
patients who developed SSI 2 in group 2. There were
no significant differences between the groups with
regard to overall complication rates. However, the
rate of seroma occurrence was significantly higher
in group 2 (P , 0.041). Five patients who developed
seroma and then SSI 2–type infection had a longer
operation time and greater hernia and mesh size. It
was thus suggested that operational dissection and
the resulting seroma may have been larger. We
believe that in patients with inadequate fluid
drainage, the fluid collection becomes infected and
facilitates mesh infection over time. One of 7
patients in group 2 who developed SSI 2–type
infection also had a bleeding complication. That
patient was operated on early, and hemostasis was
achieved. We think that reoperation increased the
risk of infection in this patient.
Although there are some studies suggesting a
conservative approach would be more effective in
treating mesh infections,31 the overall tendency of
surgeons is to remove the infected synthetic mesh.
Some studies have argued the beneficial effects of
using VAC during conservative approach.31 In our
study, we removed the synthetic mesh in 3 patients
with SSI-2 infection, all of whom were in group 2.
Table 5 Original incision leading to the ventral hernia
Incision type Group 1, n (%) Group 2, n (%) Total, n (%)
Midline: xiphoid to pubis 10 (38.4) 13 (50) 23 (44.2)
Midline: upper abdominal 3 (11.5) 4 (15.2) 7 (13.4)
Pfannenstiel 3 (11.5) 4 (15.2) 7 (13.4)
Right paramedian transrectus 4 (15.2) 1 (3.8) 5 (9.6)
Midline: infraumbilical 2 (7.6) 1 (3.8) 3 (5.7)
Midline: umbilical 1 (3.8) 2 (7.6) 3 (5.7)
Transverse umbilical 1 (3.8) 1 (3.8) 2 (3.8)
McBurney – 1 (3.8) 1 (1.9)
Flank 1 (3.8) – 1 (1.9)
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Two patients in that group first received VAC
therapy and conservative therapy, but no adequate
response could be elicited.
Mesh use in VHR has been associated with
increased complication rates (such as infection,
bowel obstruction, and fistula) in previous studies.8
A study compared open mesh hernia repair and
open suture and found 2 times more complications
in mesh repair. Despite these results, however, high
recurrence rates with open suture have made mesh
repair preferable. The rate of wound-site infection is
increased 4-fold after the use of absorbable mesh. It
was reported that permanent mesh use was not
predictive of incident wound infections.18 We used
nonabsorbable monofilament mesh in all patients to
reduce both the recurrence rates and the infection
risk.
Among many risk factors for wound infection
after VHR, smoking appears to be the only
preventable risk factor.18 Unfortunately, most pa-
tient-related risk factors could not be eliminated,
despite all efforts. At this point, intraoperative
variables have begun to come to the forefront.
Operation room sterilization conditions, personnel
training, surgical expertise, surgical-field cleansing,
a reduced contact of mesh with surgical field, and
prophylactic antibiotic use are the preventable
factors. Furthermore, animal studies have recently
suggested that synthetic meshes soaked in antibiotic
solution to attain higher antibiotic levels reduced
infection rates. Our results are not in agreement
with those obtained in animal trials,13,14 since our
control group developed less surgical-field infec-
tion.
Conclusion
Use of synthetic mesh soaked in Vancomycin
solution had no beneficial effect on wound-site
infection. This may have been because the majority
of proliferated bacteria were different from the
members of normal skin flora, and thus Vancomycin
had limited effect. Future randomized, controlled,
large-scale studies using the same mesh and suture
types for VHR, and meshes soaked in larger
spectrum antibiotics are needed.
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